€50 loan from European Investment Bank to Israeli company Pluristem
[Arutz 7] - The European Investment Bank (EIB) has announced that it is to partner with the Israel Innovation Authority to pursue investment opportunities in the domain of bio-convergence in health.
The EIB will be supporting Israeli company Pluristem via its German subsidiary, with a venture loan of €50 million.
Pluristem is a regenerative medicine company with a focus on novel biological products. The company uses cells derived from placenta for the development of product candidates for the treatment of severe medical conditions.
Posted by: g(r)omgoru 2020-04-30 |